RT Book, Section
A1 Wanchoo, Rimda
A1 Parikh, Nishita
A1 Jhaveri, Kenar D.
A2 Lerma, Edgar V.
A2 Rosner, Mitchell H.
A2 Perazella, Mark A.
SR Print(0)
ID 1149112899
T1 The Kidney in Malignancy
T2 CURRENT Diagnosis & Treatment: Nephrology & Hypertension, 2e
YR 2017
FD 2017
PB McGraw-Hill Education
PP New York, NY
SN 9781259861055
LK accessmedicine.mhmedical.com/content.aspx?aid=1149112899
RD 2024/04/19
AB Onconephrology  is  a  new  and  evolving  subspecialty  that  focuses  on  all  aspects  of  kidney  disease  in  cancer  patients.  Given  that  up  to  a  quarter  of  patients  with  a  cancer  diagnosis  will  develop  some  form  of  kidney  impairment,  a  discipline  that  aims  to  understand  and  manage  the  overlapping  fields  of  nephrology  and  oncology  is  needed.  Topics  considered  to  be  part  of  onconephrology  are  electrolyte  disorders  of  malignancy,  secondary  glomerular  diseases  of  cancer,  chemotherapy  and  targeted  therapy-related  kidney  complications,  paraproteinemias,  thrombotic  microangiopathies,  hematopoietic  stem  cell  transplant  (HSCT)-related  kidney  diseases,  tumor  lysis  syndrome,  and  acute  kidney  injury  (AKI)  in  the  cancer  patient.  Other  topics  include  the  ethics  of  providing  dialysis  in  a  dying  cancer  patient,  postnephrectomy  kidney  disease  and  obstructive  nephropathy,  dosing  of  chemotherapy  in  chronic  kidney  disease  (CKD)  patients,  and  renal  cell  cancer.  This  chapter  serves  as  an  overview  of  key  onconephrology  topics.